Your session is about to expire
← Back to Search
Hyperpolarized Pyruvate Imaging for Cancer
Study Summary
This trial is testing whether a new imaging agent can help doctors more accurately see how diseases like cancer are affecting a patient's organs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot or will not have an IV line placed for a pyruvate injection.I do not have any severe illnesses like heart problems.My liver function tests are within normal limits.My kidney function is reduced with creatinine levels high or clearance low.My cancer diagnosis was confirmed by a pathology department, or I have suspected brain cancer based on MRI.My cancer can be measured or seen on scans, with a tumor larger than 1cm.I am not pregnant, confirmed by a recent test.I have sarcoma, prostate, breast, brain, metastatic, or pancreatic cancer.
- Group 1: Hyperpolarized Pyruvate MRI Reproducibility
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Am I eligible to take part in this clinical trial?
"This clinical trial is admitting 109 individuals with a malignant solid tumour aged between 21 and 90 years old. Patients must afford the following prerequisites: histologically verified neoplasm (with an exclusion for those with brain lesions that have radiologic features suggestive of cancer), measurable or evaluable disease as characterized by RECIST 1.1, mass larger than 1cm in length-axis, negative serum/urine pregnancy test if female patient can potentially bear children according to MSKCC Standard & Guidelines; this study will only accept patients suffering from sarcoma, prostate, breast, brain metastatic or pancreatic cancer. Further alterations may"
Are geriatric individuals excluded from participating in this research trial?
"This trial is available to patients aged 21 - 90. Additionally, there are two sub-studies open for participants younger than 18 as well as 16 studies that cater to those above 65 years of age."
How many individuals can take part in this clinical experiment?
"Affirmative. Clinicaltrials.gov attests that this research endeavour, which was initially posted on April 1st 2015, is actively enrolling participants. Approximately 109 individuals need to be recruited from 2 separate medical centres."
Is this experiment actively seeking participants?
"Affirmative. Based on the information hosted on clinicaltrials.gov, this trial is actively searching for participants to join their study. It was initiated in April 2015 and lastly updated in August 2022; they are looking to enroll 109 individuals at two different medical centres."
Share this study with friends
Copy Link
Messenger